John T. Kissel

Neurology
2050 Kenny Rd Fl 7
Columbus, OH 43221

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

The Neuropathies of Vasculitis.

The Neuropathies of Vasculitis.

Journal: Neurologic clinics
Published: October 29, 2025

Guillain-Barré Syndrome and Variants.

Guillain-Barré Syndrome and Variants.

Journal: Neurologic clinics
Published: October 29, 2025

Autonomic Neuropathies.

Autonomic Neuropathies.

Journal: Neurologic clinics
Published: October 29, 2025

Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.

Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.

Journal: JAMA neurology
Published: October 23, 2023

The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.

The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.

Journal: Muscle & nerve
Published: January 25, 2023

A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).

A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).

Journal: Muscle & nerve
Published: December 15, 2022

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.

Journal: The Lancet. Neurology
Published: October 07, 2022

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.

Journal: BMJ open
Published: September 19, 2020

Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study.

Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study.

Journal: Neurology
Published: September 11, 2020

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.

Journal: JAMA neurology
Published: August 19, 2020

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.

Journal: Neurology
Published: August 12, 2020

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

Journal: Neurology
Published: July 01, 2020
Showing 1-12 of 100

Last Updated: 09/26/2026